Home/Filings/4/0001209191-21-004330
4//SEC Filing

Marek David C 4

Accession 0001209191-21-004330

CIK 0001679082other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:41 PM ET

Size

7.8 KB

Accession

0001209191-21-004330

Insider Transaction Report

Form 4
Period: 2021-01-15
Marek David C
DirectorPrincipal Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-01-15+306,427306,427 total
    Exercise: $20.54Exp: 2031-01-14Common Stock (306,427 underlying)
  • Award

    Common Shares

    2021-01-15+223,076223,076 total
Footnotes (2)
  • [F1]The common shares are to be acquired upon the vesting of certain Restricted Stock Units ("RSUs") granted to the Reporting Person. The RSUs shall vest as follows: 1/4 of the common shares underlying this restricted stock unit award under the Myovant Sciences Ltd. 2020 Inducement Plan vest on January 15, 2022, and 1/16 of the common shares underlying this restricted stock unit award vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
  • [F2]1/4 of the common shares underlying this option under the Myovant Sciences Ltd. 2020 Inducement Plan vest on January 15, 2022, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.

Issuer

Myovant Sciences Ltd.

CIK 0001679082

Entity typeother

Related Parties

1
  • filerCIK 0001556914

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:41 PM ET
Size
7.8 KB